مورد إلكتروني
Tools for Survivorship Care Planning in Uterine Serous Carcinoma
| العنوان: | Tools for Survivorship Care Planning in Uterine Serous Carcinoma |
|---|---|
| المصدر: | Conference; SGO 2022; RITM0020434Nolin2022Poster.pdf; Digital collection created by the USUHS Archives, Uniformed Services University of the Health Sciences. |
| بيانات النشر: | Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 2022 |
| تفاصيل مُضافة: | School of Medicine Angela Nolin Chunqiao Tian PhD, Chad A. Hamilton MD, Yovanni Casablanca MD, Nicholas W. Bateman PhD, John K. Chan MD, Michelle L. Cote PhD, Craig D. Shriver MD, Matthew A. Powell MD, Neil T. Phippen MD, Thomas P. Conrads PhD, G. Larry Maxwell MD, and Kathleen M. Darcy PhD |
| نوع الوثيقة: | Electronic Resource |
| وصف مادي: | 1 online resource (1 poster) |
| مستخلص: | FUNDING: This research was funded by awards from the Uniformed Services University of the Health Sciences from the Defense Health Program to the Henry M Jackson Foundation (HJF) for the Advancement of Military Medicine, Inc. including awards HU0001-16-2-0006, HU0001-19-2-0031, HU0001-20-2-0033, and HU0001-21-2-0027 to the Gynecologic Cancer Center of Excellence Program (PI: Yovanni Casablanca, Co-PI: G. Larry Maxwell) and award HU0001-18-2-0032 to the Murtha Cancer Center Research Program (PI: Craig D. Shriver). DISCLAIMER: The views expressed herein are those of the authors and do not reflect the official policy of the Uniformed Services University of the Health Sciences, the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Inova Health System, the Department of Army/Navy/Air Force, Department of Defense, or U.S. Government. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government. PURPOSE METHODS RESULTS A. Overall Survival Estimates by Stage at Diagnosis B. Incremental 5-Year Conditional Survival by Stage C. Initial Treatment-Related Survival at Diagnosis D. Conditional Treatment-Related Survival after 5-Years CONCLUSIONS Fig. 1. Overall survival distributions by stage in women uterine serous carcinoma (A). The 5-year conditional survival rate and 95% confidence interval were estimated by stage in women with USC who survived at least 1 to 5 years after diagnosis (B). Treatment-related survival at the time of diagnosis (C) and conditioned on surviving 5-years (D) were estimated with adjusted HR and 95% CI for risk of death from Cox modeling controlling for clinical characteristics in Table 1 relative to no lymphadenectomy or no adjuvant radiation, chemotherapy or chemotherapy and radiation. NA: analysis was not applicable due to limited sample size. Ø Develop stage-stratified survivorship estimates for uterine serous carcinoma (USC) Ø Determine if the relationship between first-line RITM0020434 Develop stage-stratified survivorship estimates for uterine serous carcinoma (USC). Determine if the relationship between first-line treatment or prognostic factors and survival is modified after surviving 5-years. |
| مصطلحات الفهرس: | Cystadenocarcinoma, Serous, SGO 2022, Other, Posters |
| URL: | USUHS Posters |
| الإتاحة: | Open access content. Open access content U.S. Government The views presented here are those of the author and are not to be construed as official or reflecting the views of the Uniformed Services University of the Health Sciences, the Department of Defense or the U.S. Government. |
| ملاحظة: | pdf University Archives, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 Digital collection created by the USUHS Archives, Uniformed Services University of the Health Sciences. |
| أرقام أخرى: | USU oai:cdm16005.contentdm.oclc.org:p16005coll8/110 1351838494 |
| المصدر المساهم: | UNIFORMED SERV UNIV OF THE HEALTH SCI From OAIster®, provided by the OCLC Cooperative. |
| رقم الأكسشن: | edsoai.on1351838494 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |